- Home
- WGSWW vs XPOF Comparison
WGSWW vs XPOF Comparison
Compare WGSWW & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- XPOF
- Stock Information
- Founded
- WGSWW 2017
- XPOF 2017
- Country
- WGSWW United States
- XPOF United States
- Employees
- WGSWW 1000
- XPOF N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- XPOF Services-Misc. Amusement & Recreation
- Sector
- WGSWW Technology
- XPOF Consumer Discretionary
- Exchange
- WGSWW Nasdaq
- XPOF Nasdaq
- Market Cap
- WGSWW N/A
- XPOF N/A
- IPO Year
- WGSWW N/A
- XPOF 2021
- Fundamental
- Price
- WGSWW $0.05
- XPOF $8.14
- Analyst Decision
- WGSWW
- XPOF Buy
- Analyst Count
- WGSWW 0
- XPOF 9
- Target Price
- WGSWW N/A
- XPOF $14.72
- AVG Volume (30 Days)
- WGSWW 36.6K
- XPOF 618.3K
- Earning Date
- WGSWW 02-18-2025
- XPOF 05-08-2025
- Dividend Yield
- WGSWW N/A
- XPOF N/A
- EPS Growth
- WGSWW N/A
- XPOF N/A
- EPS
- WGSWW N/A
- XPOF N/A
- Revenue
- WGSWW $305,450,000.00
- XPOF $317,536,000.00
- Revenue This Year
- WGSWW N/A
- XPOF $1.71
- Revenue Next Year
- WGSWW N/A
- XPOF $6.88
- P/E Ratio
- WGSWW N/A
- XPOF N/A
- Revenue Growth
- WGSWW 50.79
- XPOF N/A
- 52 Week Low
- WGSWW $0.17
- XPOF $6.64
- 52 Week High
- WGSWW $0.21
- XPOF $18.95
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- XPOF 46.93
- Support Level
- WGSWW N/A
- XPOF $8.07
- Resistance Level
- WGSWW N/A
- XPOF $9.05
- Average True Range (ATR)
- WGSWW 0.00
- XPOF 0.42
- MACD
- WGSWW 0.00
- XPOF 0.18
- Stochastic Oscillator
- WGSWW 0.00
- XPOF 54.73
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.